IN SILICO SOLUTIONS

in-silico-solutions-logo

In Silico Solutions is a bioinformatics services company that performs data analysis and software tool development for genome-wide research projects. We started as a bioinformatics division within Tiger Team Consulting and spun off as a separate company in 2007. In Silico employs top notch scientists and technicians with extensive experience in bioinformatics and biostatistics. Our background in professional software development allows us to apply methods and practices that deliver a level of qu... ality that is often missing from research oriented software. The company headquarters is located in Fairfax, VA. We perform contract research and collaborate on grant funded research with academic, government, and commercial organizations located throughout the United States. We are proud of our long term relationships with premier research institutions including MD Anderson Cancer Center, the National Institute of Health, Johns Hopkins Institute for Computational Medicine, and the University of California Santa Cruz Genome Bioinformatics Group. In Silico is run by its founder, Dr. Michael Ryan, who has over 20 years experience in software development and a PhD in Bioinformatics. Led by Dr. Ryan, In Silico has established a reputation for bringing professional software development practices to the field of bioinformatics and for developing practical, biologist-friendly solutions to complex genome-scale analysis issues.

#SimilarOrganizations #Website #More

IN SILICO SOLUTIONS

Industry:
Analytics Bioinformatics Biotechnology Software

Address:
Fairfax, Virginia, United States

Country:
United States

Website Url:
http://www.insilico.us.com

Status:
Active

Contact:
703-626-5653

Email Addresses:
info@insilico.us.com

Technology used in webpage:
Google Font API AJAX Libraries API OpenResty SEO_H1


Similar Organizations

genedrop-logo

GeneDrop

GeneDrop develops bioinformatics software to help in the analysis of genetic data.

gryphon-scientific-logo

Gryphon Scientific

Gryphon Scientific is a small business that applies scientific analysis to some of today's nation's most critical problems.

one-hill-solutions-logo

One Hill Solutions

One Hill Solutions is a software development company that produces products for data management & analytics in the bioprocess industry.

qiagen-digital-insights-logo

Qiagen Digital Insights

Qiagen Digital Insights offers a bioinformatics based analytical software platform, an extensive database, and related analytical solutions.

Official Site Inspections

http://www.insilico.us.com

  • Host name: 104.21.32.1
  • IP address: 104.21.32.1
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "In Silico Solutions"

Team | Insilico Medicine

Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in generative artificial intelligence technologies for drug discovery and biomarker development.Dr. Zhavoronkov has a combined …See details»

Media Kit | Insilico Medicine

Insilico Medicine is a global organization with headquarters in Boston and Hong Kong, and offices and labs in Montreal, Shanghai, Suzhou, and Abu Dhabi. In January 2023, Insilico announced …See details»

Insilico Medicine - Crunchbase Company Profile

Insilico Medicine is pursuing internal drug discovery programs in cancer, dermatological diseases, fibrosis, Parkinson's Disease, Alzheimer's Disease, …See details»

Insilico Medicine - LinkedIn

Insilico Medicine | 62,211 followers on LinkedIn. #insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity | Insilico Medicine, a clinical stage biotech company …See details»

GNQ Insilico

Quote from December 2020 interview with Dr. Eric Green, head of the National Human Genome Research Institute (Leading US genomic research organization.) ... GNQ Insilico Inc., 6200 Stoneridge Mall Rd, Ste 300 Pleasanton, California …See details»

Insilico Moves HQ to Cambridge, MA, Completes IPF …

Jun 20, 2024 He said Insilico is looking to reposition its business development efforts by innovating on “really ultra-high quality data packages”: “Every program, particularly for the United States ...See details»

AI for ALS

Insilico Medicine aims to develop personalized therapies for ALS patients directly by utilizing our AI drug discovery platform. After identifying novel targets in ALS and the available drugs for repurposing, we comprehensively review these …See details»

Insilico Medicine - Contacts, Employees, Board Members

Insilico Medicine has 10 current employee profiles, including Founder & Chief Executive Officer Alex Zhavoronkov. Insilico Medicine has 4 board members and advisors, including Kristen …See details»

InSilico Consulting AB

Who we are. We are a bioinformatics and data science consulting company and contract research organization (CRO) based in Lund, Sweden. With over a decade of combined industry and …See details»

Insilico licenses AI-discovered drug candidate to Menarini

Jan 13, 2025 Insilico Medicine, a company at the forefront of using AI for drug discovery, has announced a second exclusive global licensing agreement with Menarini Group’s Stemline …See details»

Insilico Biotechnology AG - Lab Manager

As a result, Insilco’s unique approach substantially reduces experimental effort, costs of goods and time to market. Leading biopharmaceutical companies worldwide use Insilico digital twins …See details»

Insilico - 2025 Company Profile, Funding & Competitors - Tracxn

3 days ago Insilico - AI-enabled bioinformatics platform for drug discovery and biomarker development. Raised a total funding of $500M over 10 rounds from 37 investors. Founded by …See details»

In Silico Solutions - Crunchbase Company Profile & Funding

In Silico employs top notch scientists and technicians with extensive experience in. bioinformatics and biostatistics. Our background in professional software development allows us to apply …See details»

Why I Left Big Pharma for AI: Insilico Medicine’s Co-CEO Dr. Feng …

Jun 16, 2022 Since 2021, Insilico has delivered eight preclinical candidates designed using its AI platform targeting fibrosis, cancer, anemia, and inflammatory bowel disease. The team …See details»

Position paper: Extending Credibility Assessment of In Silico …

4 days ago There are several situations where it would be convenient if a quantity of interest essential to support a medical or regulatory decision could be predicted as a function of other …See details»

Home - insilico Lab

Insilico Lab Empowering Research Through Computational Innovation Read More About us insilico Lab At insilicoLab, we are dedicated to transforming the way researchers access and …See details»

Insilico Logix Reviews: What Is It Like to Work At Insilico Logix?

Is Insilico Logix a good company to work for? Insilico Logix has an overall rating of 4.0 out of 5, based on over 26 reviews left anonymously by employees. 84% of employees would …See details»

Computational drug repurposing: approaches, evaluation of in …

3 days ago Finding new uses for approved drugs, known as drug repurposing, is a widely applicable strategy to alleviate the high costs of drug development and to address unmet …See details»

Ansys and NVIDIA to Demonstrate New Era of In-Silico …

3 days ago Ansys (NASDAQ: ANSS) and NVIDIA have unveiled a groundbreaking technology framework that combines AI, advanced simulation, and visualization capabilities. The …See details»

From Start to Phase 1 in 30 Months | Insilico Medicine

On this same day one year ago, Insilico Medicine announced the nomination of a preclinical candidate in Idiopathic Pulmonary Fibrosis (IPF) for a novel antifibrotic target, both discovered …See details»

linkstock.net © 2022. All rights reserved